American Recovery and Reinvestment Act EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES (ELC) INFRASTRUCTURE AND INTEROPERABILITY SUPPORT FOR PUBLIC HEALTH LABORATORIES
The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
05/06/2010
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Description of Modification
No changes made.
Document Type:
Modification to Previous
Grants Notice
Funding Opportunity Number:
CDC-RFA-CI10-1007ARRA10
Opportunity Category:
Other
Posted Date:
May 06, 2010
Creation Date:
May 07, 2010
Original Closing Date for Applications:
Jun 08, 2010
Current Closing Date for Applications:
Jun 08, 2010
Archive Date:
Jul 08, 2010
Funding Instrument Type:
Other
Category of Funding Activity:
Recovery Act
Category Explanation:
Expected Number of Awards:
25
Estimated Total Program Funding:
$5,000,000
Award Ceiling:
$600,000
Award Floor:
$100,000
CFDA Number(s):
93.729
--
ARRA -Health Information Technology and Public Health
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility:
Eligibility for these awards is limited to current grantees under the ELC cooperative agreement program which include:
-50 States
-District of Columbia
-Commonwealth of Puerto Rico
-Republic of Palau
-Cities of Chicago, IL; Houston, TX; Los Angeles, CA; New York, NY; Philadelphia, PA
These 58 eligible applicants are currently funded under the following ELC Funding Opportunity Numbers:
CI04-040:
Agency Name
Centers for Disease Control and Prevention
Description
The purpose of the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) cooperative agreement is to assist state public health agencies in improving surveillance for, and response to, infectious diseases by (1) strengthening epidemiologic capacity; (2) enhancing laboratory capacity and practice; (3) improving information systems; and (4) developing and implementing prevention and control strategies. The focus of the activities is on naturally occurring infectious diseases and drug-resistant infections. ELC aims to enhance the ability of public health agencies to identify and monitor the occurrence of known infectious diseases of public health importance; detect new and emerging infectious disease threats, identify and respond to disease outbreaks; and use public health data for priority setting, policy development, and for prevention and control. Specifically within the Health Information Systems/National Electronic Disease Surveillance System (NEDSS) component of ELC, a key goal is to develop direct electronic data exchanges between sources of data (such as health care providers or laboratories – i.e., clinical care) and public health agencies.The purpose of this funding from the ARRA–HITECH Act is to support states through the ELC program to enhance and advance infrastructure and interoperability support for public health laboratories to satisfy Stage 1 Meaningful Use criteria as set out in the Centers for Medicare and Medicaid Services Meaningful Use Notice of Proposed Rule Making (published on January 13, 2010 in the Federal Register at edocket.access.gpo.gov/2010E9-31217.htm) for reporting to public health agencies using, when applicable, the HHS Standards & Certification Interim Final Rule: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology (available at edocket.access.gpo.gov/2010E9-31216.htm). These include the capability to provide electronic submission of reportable (as required by state or local law) lab results to public health agencies and actual submission where it can be received. See Appendix B for additional information on the Interim Final Rule and the Meaningful Use Notice of Proposed Rule Making.
Link to Additional Information
If you have difficulty accessing the full announcement
electronically, please contact:
The following files represent the modifications to this synopsis
with the changes noted within the documents. The list of files is
arranged from newest to oldest with the newest file representing the
current synopsis. Changed sections from the previous document are shown
in a light grey background.
